IP Library Granted Patent US 8,872,000
Granted Patent B2
US 8,872,000 · App. 13/899,452 · Granted Oct 28, 2014

Methods for plant transformation using spectinomycin selection

Inventors: Brian J. Martinell (Mt. Horeb, WI); Michael W. Petersen (Sauk City, WI); David A. Somers (Madison, WI); Yuechun Wan (Madison, WI); Edward Williams (Madison, WI); Xudong Ye (Madison, WI)
Assignee: Monsanto Technology LLC
C12N15/8271C12N15/8209G01N33/0098C12N5/04A01H4/003C12N15/8201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,872,000
App. No.
13/899,452
Granted
Oct 28, 2014
Kind
B2
Abstract

The present invention relates to methods and compositions for transforming soybean, corn, cotton, or canola explants using spectinomycin as a selective agent for transformation of the explants. The method may further comprise treatment of the explants with cytokinin during the transformation and regeneration process.

Claims (7)

1. A method for producing a transgenic canola plant containing at least two heterologous nucleic acid sequences, comprising:

(a) providing a canola explant comprising a first heterologous nucleic acid sequence that confers resistance to an herbicide or that confers resistance to kanamycin and related aminoglycosides;

(b) transforming the explant to comprise a second heterologous nucleic acid sequence comprising a selectable marker gene conferring spectinomycin resistance, wherein the selectable marker gene comprises an aadA gene fused to a sequence encoding a chloroplast transit peptide; and

(c) regenerating an explant from step (b) that exhibits spectinomycin resistance into a transgenic canola plant containing at least the first and second heterologous nucleic acid sequences.

2. The method of claim 1 , wherein the explant comprises an embryonic meristem.

3. The method of claim 1 , wherein the first heterologous nucleic acid sequence confers resistance to glyphosate, bialaphos, phosphinothricin, Basta, glufosinate, 2,4-D, kanamycin and related aminoglycosides, hygromycin, an acetyl-coA carboxylase inhibitor, an oxygen radical generator, or dicamba.

4. The method of claim 1 , wherein the transgenic plant arises from transformation of a meristem that results in transformation of germline tissue.

Continuity (5)
Division 13213021 · Aug 18, 2011
Division 12045562 · Mar 10, 2008
Provisional Application 60894096 · Mar 9, 2007
Provisional Application 60915066 · Apr 30, 2007
Related Publication 20140007299A1 · Jan 2, 2014